Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
13.36
-0.24 (-1.76%)
Aug 14, 2025, 12:02 PM - Market open

Maze Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
264.54196.8129.1699.92
Cash & Short-Term Investments
264.54196.8129.1699.92
Cash Growth
51.11%574.99%-70.82%-
Prepaid Expenses
6.614.864.956.23
Total Current Assets
271.15201.6734.11106.15
Property, Plant & Equipment
27.7129.9234.9841.23
Long-Term Deferred Charges
-4.6--
Other Long-Term Assets
4.664.352.412.58
Total Assets
303.52240.5471.5149.96
Accounts Payable
3.671.942.021.59
Accrued Expenses
11.5214.19.8114.87
Current Portion of Leases
4.724.634.494.32
Total Current Liabilities
19.920.6716.3220.78
Long-Term Debt
--20.08-
Long-Term Leases
20.292225.0527.73
Other Long-Term Liabilities
1.090.97--
Total Liabilities
41.2843.6461.4548.51
Common Stock
0.04000.02
Additional Paid-In Capital
687.0947.2421.8412.79
Retained Earnings
-424.89-358.43-395.69-295.27
Total Common Equity
262.24-311.18-373.85-282.46
Shareholders' Equity
262.24196.910.05101.44
Total Liabilities & Equity
303.52240.5471.5149.96
Total Debt
25.0126.6349.6232.06
Net Cash (Debt)
239.53170.18-20.4767.86
Net Cash Per Share
12.3862.33-8.9433.76
Filing Date Shares Outstanding
43.8543.82.322.01
Total Common Shares Outstanding
43.852.442.322.01
Working Capital
251.2518117.7985.37
Book Value Per Share
5.98-127.72-160.95-140.52
Tangible Book Value
262.24-311.18-373.85-282.46
Tangible Book Value Per Share
5.98-127.72-160.95-140.52
Machinery
-17.3116.4716.08
Construction In Progress
-0.030.06-
Leasehold Improvements
-5.455.365.33
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q